# Twilio timeline entity: /record/twilio.md id: ent_twilio ## undated - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_26753DC34476](/claim/clm_26753DC34476.md) - undated | fiscal_year_end | 12-31 | valid | [clm_369715279A79](/claim/clm_369715279A79.md) - undated | registrant_name | TWILIO INC | valid | [clm_5C5CABB25962](/claim/clm_5C5CABB25962.md) - undated | listed_on | NYSE | valid | [clm_5F726B3C5EC2](/claim/clm_5F726B3C5EC2.md) - undated | cik | 0001447669 | valid | [clm_B36034DD3894](/claim/clm_B36034DD3894.md) - undated | state_of_incorporation | DE | valid | [clm_BA248BBE6C76](/claim/clm_BA248BBE6C76.md) - undated | ticker | TWLO | valid | [clm_BB9F3F5B169C](/claim/clm_BB9F3F5B169C.md) - undated | member_of | Internet Association | unverified | [clm_4AD815C455D4](/claim/clm_4AD815C455D4.md) - undated | country | United States | unverified | [clm_6421AC1DEE49](/claim/clm_6421AC1DEE49.md) - undated | headquarters | San Francisco | unverified | [clm_85296D3B3C90](/claim/clm_85296D3B3C90.md) - undated | industry | software development | unverified | [clm_8DAB9FFBE7A2](/claim/clm_8DAB9FFBE7A2.md) - undated | website | http://www.twilio.com/ | unverified | [clm_A53F781ACA8C](/claim/clm_A53F781ACA8C.md) - undated | website | http://www.authy.com | unverified | [clm_B535A7F3FB09](/claim/clm_B535A7F3FB09.md) - undated | member_of | Business Software Alliance | valid | [clm_D02B6565F84D](/claim/clm_D02B6565F84D.md) - undated | legal_form | Delaware corporation | unverified | [clm_E5625F90B8CF](/claim/clm_E5625F90B8CF.md) ## 2008 - 2008-08-21 | x_username | twilio | unverified | [clm_961507E9C72D](/claim/clm_961507E9C72D.md) ## 2012 - 2012-01-25 | x_username | TwilioHelp | unverified | [clm_26949535A032](/claim/clm_26949535A032.md) ## 2013 - 2013-12-31 to 2014-12-31 | total_equity | 52,900,000 United States dollar | superseded | [clm_8DA3ACD4309B](/claim/clm_8DA3ACD4309B.md) - 2013-12-31 to 2014-12-31 | cash_and_equivalents | 54,715,000 United States dollar | superseded | [clm_ACD1D9CB80A2](/claim/clm_ACD1D9CB80A2.md) ## 2014 - 2014-11-18 | x_username | TwilioIRL | unverified | [clm_858B3CA0627D](/claim/clm_858B3CA0627D.md) - 2014-12-31 to 2015-12-31 | research_and_development | 21,824,000 United States dollar | superseded | [clm_1CC746341303](/claim/clm_1CC746341303.md) - 2014-12-31 to 2015-12-31 | net_income | -26,758,000 United States dollar | superseded | [clm_27DFE7022B64](/claim/clm_27DFE7022B64.md) - 2014-12-31 to 2015-12-31 | revenue | 88,846,000 United States dollar | superseded | [clm_3D161BA95EE9](/claim/clm_3D161BA95EE9.md) - 2014-12-31 to 2015-06-30 | cash_and_equivalents | 32,627,000 United States dollar | superseded | [clm_5D6E34B925F2](/claim/clm_5D6E34B925F2.md) - 2014-12-31 to 2015-12-31 | operating_income | -26,683,000 United States dollar | superseded | [clm_79EA8F287FEB](/claim/clm_79EA8F287FEB.md) - 2014-12-31 to 2015-12-31 | total_equity | 31,194,000 United States dollar | superseded | [clm_C5AFDC9CC913](/claim/clm_C5AFDC9CC913.md) ## 2015 - 2015-06-30 to 2015-09-30 | quarterly_net_income | -9,576,000 United States dollar | superseded | [clm_140BFB5EB9F1](/claim/clm_140BFB5EB9F1.md) - 2015-06-30 to 2015-09-30 | quarterly_research_and_development | 9,388,000 United States dollar | superseded | [clm_8758D5D5C944](/claim/clm_8758D5D5C944.md) - 2015-06-30 to 2015-09-30 | quarterly_operating_income | -9,460,000 United States dollar | superseded | [clm_89DD024B77DC](/claim/clm_89DD024B77DC.md) - 2015-06-30 to 2015-09-30 | cash_and_equivalents | 121,821,000 United States dollar | superseded | [clm_909B1AEF9D21](/claim/clm_909B1AEF9D21.md) - 2015-06-30 to 2015-09-30 | quarterly_revenue | 37,954,000 United States dollar | superseded | [clm_DD885D60D81B](/claim/clm_DD885D60D81B.md) - 2015-09-30 to 2015-12-31 | cash_and_equivalents | 115,994,000 United States dollar | superseded | [clm_A776FA24582E](/claim/clm_A776FA24582E.md) - 2015-09-30 to 2016-03-31 | quarterly_research_and_development | 11,602,000 United States dollar | superseded | [clm_B62EBE508AEC](/claim/clm_B62EBE508AEC.md) - 2015-09-30 to 2016-03-31 | quarterly_revenue | 44,262,000 United States dollar | superseded | [clm_C7F5C6984B60](/claim/clm_C7F5C6984B60.md) - 2015-09-30 to 2016-03-31 | quarterly_net_income | -9,008,000 United States dollar | superseded | [clm_D0FCB1098C10](/claim/clm_D0FCB1098C10.md) - 2015-09-30 to 2016-03-31 | quarterly_operating_income | -8,944,000 United States dollar | superseded | [clm_FCBE4F1FCA2C](/claim/clm_FCBE4F1FCA2C.md) - 2015-12-31 to 2016-06-30 | total_equity | 116,625,000 United States dollar | superseded | [clm_4D84B32BB150](/claim/clm_4D84B32BB150.md) - 2015-12-31 to 2016-12-31 | net_income | -35,504,000 United States dollar | superseded | [clm_7417D780B9EE](/claim/clm_7417D780B9EE.md) - 2015-12-31 to 2016-12-31 | operating_income | -35,393,000 United States dollar | superseded | [clm_78F919DE73AB](/claim/clm_78F919DE73AB.md) - 2015-12-31 to 2016-12-31 | revenue | 166,919,000 United States dollar | superseded | [clm_94AEA72197F9](/claim/clm_94AEA72197F9.md) - 2015-12-31 to 2016-03-31 | cash_and_equivalents | 108,835,000 United States dollar | superseded | [clm_BED5133B1605](/claim/clm_BED5133B1605.md) - 2015-12-31 to 2016-12-31 | research_and_development | 42,559,000 United States dollar | superseded | [clm_C3038F0242FE](/claim/clm_C3038F0242FE.md) - 2015-12-31 to 2016-06-30 | total_assets | 157,516,000 United States dollar | superseded | [clm_F74D887EDC42](/claim/clm_F74D887EDC42.md) ## 2016 - 2016-03-31 to 2016-06-30 | quarterly_net_income | -6,468,000 United States dollar | superseded | [clm_3F52A4C0759D](/claim/clm_3F52A4C0759D.md) - 2016-03-31 to 2016-06-30 | quarterly_revenue | 59,340,000 United States dollar | superseded | [clm_544A42F74931](/claim/clm_544A42F74931.md) - 2016-03-31 to 2016-06-30 | cash_and_equivalents | 103,320,000 United States dollar | superseded | [clm_60B610C32FF3](/claim/clm_60B610C32FF3.md) - 2016-03-31 to 2016-06-30 | quarterly_research_and_development | 14,864,000 United States dollar | superseded | [clm_BC72681CD7FF](/claim/clm_BC72681CD7FF.md) - 2016-03-31 to 2016-06-30 | quarterly_operating_income | -6,366,000 United States dollar | superseded | [clm_F3BA4FDC7833](/claim/clm_F3BA4FDC7833.md) - 2016-06-30 to 2016-09-30 | quarterly_revenue | 64,510,000 United States dollar | superseded | [clm_021B6E7E4072](/claim/clm_021B6E7E4072.md) - 2016-06-30 to 2016-09-30 | total_assets | 336,551,000 United States dollar | superseded | [clm_1329209F0481](/claim/clm_1329209F0481.md) - 2016-06-30 to 2016-09-30 | quarterly_research_and_development | 17,369,000 United States dollar | superseded | [clm_23D88E8C8D42](/claim/clm_23D88E8C8D42.md) - 2016-06-30 to 2016-09-30 | total_equity | 267,233,000 United States dollar | superseded | [clm_53E1A1F7846B](/claim/clm_53E1A1F7846B.md) - 2016-06-30 to 2016-09-30 | quarterly_operating_income | -10,853,000 United States dollar | superseded | [clm_AB74157FCE34](/claim/clm_AB74157FCE34.md) - 2016-06-30 to 2016-09-30 | quarterly_net_income | -10,994,000 United States dollar | superseded | [clm_B650A3496DA4](/claim/clm_B650A3496DA4.md) - 2016-06-30 to 2016-09-30 | cash_and_equivalents | 261,386,000 United States dollar | superseded | [clm_E054FD6732A0](/claim/clm_E054FD6732A0.md) - 2016-09-30 to 2017-03-31 | quarterly_net_income | -11,254,000 United States dollar | superseded | [clm_099140EFB540](/claim/clm_099140EFB540.md) - 2016-09-30 to 2016-12-31 | total_equity | 264,274,000 United States dollar | superseded | [clm_0CAC62A79BCE](/claim/clm_0CAC62A79BCE.md) - 2016-09-30 to 2017-03-31 | quarterly_revenue | 71,533,000 United States dollar | superseded | [clm_2C8CFF022A1F](/claim/clm_2C8CFF022A1F.md) - 2016-09-30 to 2016-12-31 | cash_and_equivalents | 252,225,000 United States dollar | superseded | [clm_5224E6ABC157](/claim/clm_5224E6ABC157.md) - 2016-09-30 to 2016-12-31 | total_assets | 340,566,000 United States dollar | superseded | [clm_BD5BC0E1C297](/claim/clm_BD5BC0E1C297.md) - 2016-09-30 to 2017-03-31 | quarterly_research_and_development | 21,106,000 United States dollar | superseded | [clm_C418EDAA01FE](/claim/clm_C418EDAA01FE.md) - 2016-09-30 to 2017-03-31 | quarterly_operating_income | -11,276,000 United States dollar | superseded | [clm_C5C26535B484](/claim/clm_C5C26535B484.md) - 2016-12-31 to 2017-03-31 | cash_and_equivalents | 305,665,000 United States dollar | superseded | [clm_46BC13343F88](/claim/clm_46BC13343F88.md) - 2016-12-31 to 2017-12-31 | research_and_development | 77,926,000 United States dollar | superseded | [clm_63E5A12C8509](/claim/clm_63E5A12C8509.md) - 2016-12-31 to 2017-12-31 | operating_income | -41,315,000 United States dollar | superseded | [clm_AAA79FC7816D](/claim/clm_AAA79FC7816D.md) - 2016-12-31 to 2017-12-31 | revenue | 277,335,000 United States dollar | superseded | [clm_B24359B4B699](/claim/clm_B24359B4B699.md) - 2016-12-31 to 2017-03-31 | total_assets | 412,694,000 United States dollar | superseded | [clm_E7ACADF3AF15](/claim/clm_E7ACADF3AF15.md) - 2016-12-31 to 2017-12-31 | net_income | -41,324,000 United States dollar | superseded | [clm_EA1A32243984](/claim/clm_EA1A32243984.md) - 2016-12-31 to 2017-03-31 | total_equity | 329,447,000 United States dollar | superseded | [clm_F281755C029F](/claim/clm_F281755C029F.md) ## 2017 - 2017-03-31 to 2017-06-30 | total_assets | 429,766,000 United States dollar | superseded | [clm_6673C73F12DF](/claim/clm_6673C73F12DF.md) - 2017-03-31 to 2017-06-30 | quarterly_operating_income | -14,755,000 United States dollar | superseded | [clm_86E9AB089D5A](/claim/clm_86E9AB089D5A.md) - 2017-03-31 to 2018-03-31 | quarterly_net_income | -14,227,000 United States dollar | superseded | [clm_8F3929BC576A](/claim/clm_8F3929BC576A.md) - 2017-03-31 to 2017-06-30 | cash_and_equivalents | 118,440,000 United States dollar | superseded | [clm_AE1F5C4A8D81](/claim/clm_AE1F5C4A8D81.md) - 2017-03-31 to 2017-06-30 | total_equity | 337,860,000 United States dollar | superseded | [clm_B0F53E547823](/claim/clm_B0F53E547823.md) - 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 26,522,000 United States dollar | superseded | [clm_CA9CFC1092AE](/claim/clm_CA9CFC1092AE.md) - 2017-03-31 to 2017-06-30 | quarterly_revenue | 87,372,000 United States dollar | superseded | [clm_DB2149E89E20](/claim/clm_DB2149E89E20.md) - 2017-06-30 to 2017-09-30 | quarterly_revenue | 95,870,000 United States dollar | superseded | [clm_028CC3858E8E](/claim/clm_028CC3858E8E.md) - 2017-06-30 to 2017-09-30 | cash_and_equivalents | 92,184,000 United States dollar | superseded | [clm_240BFA09D277](/claim/clm_240BFA09D277.md) - 2017-06-30 to 2017-09-30 | total_equity | 358,108,000 United States dollar | superseded | [clm_672E6CDC4F43](/claim/clm_672E6CDC4F43.md) - 2017-06-30 to 2017-09-30 | total_assets | 437,947,000 United States dollar | superseded | [clm_DA606A238CE6](/claim/clm_DA606A238CE6.md) - 2017-06-30 to 2017-09-30 | quarterly_operating_income | -7,070,000 United States dollar | superseded | [clm_F982165BB6B9](/claim/clm_F982165BB6B9.md) - 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 29,714,000 United States dollar | superseded | [clm_FE5D96163201](/claim/clm_FE5D96163201.md) - 2017-09-30 to 2017-12-31 | total_equity | 355,000,000 United States dollar | superseded | [clm_0651C181674E](/claim/clm_0651C181674E.md) - 2017-09-30 to 2017-12-31 | total_assets | 443,548,000 United States dollar | superseded | [clm_0FC41FD42B15](/claim/clm_0FC41FD42B15.md) - 2017-09-30 to 2017-12-31 | cash_and_equivalents | 91,906,000 United States dollar | superseded | [clm_6BC1D329E98F](/claim/clm_6BC1D329E98F.md) - 2017-09-30 to 2018-03-31 | quarterly_operating_income | -24,031,000 United States dollar | superseded | [clm_70BC86C07EC3](/claim/clm_70BC86C07EC3.md) - 2017-09-30 to 2018-03-31 | quarterly_revenue | 100,542,000 United States dollar | superseded | [clm_F519F9552ED8](/claim/clm_F519F9552ED8.md) - 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 31,674,000 United States dollar | superseded | [clm_F7906813354E](/claim/clm_F7906813354E.md) - 2017-12-31 to 2018-12-31 | operating_income | -66,074,000 United States dollar | superseded | [clm_234890AB4CEE](/claim/clm_234890AB4CEE.md) - 2017-12-31 to 2018-03-31 | total_equity | 359,846,000 United States dollar | superseded | [clm_2468BA2F423F](/claim/clm_2468BA2F423F.md) - 2017-12-31 to 2018-03-31 | total_assets | 449,782,000 United States dollar | superseded | [clm_2F73F4EA9280](/claim/clm_2F73F4EA9280.md) - 2017-12-31 to 2018-12-31 | research_and_development | 120,739,000 United States dollar | superseded | [clm_5840E6AC8492](/claim/clm_5840E6AC8492.md) - 2017-12-31 to 2018-12-31 | revenue | 399,020,000 United States dollar | superseded | [clm_94602AE39194](/claim/clm_94602AE39194.md) - 2017-12-31 to 2018-12-31 | net_income | -63,708,000 United States dollar | superseded | [clm_B602C3FF4131](/claim/clm_B602C3FF4131.md) - 2017-12-31 to 2018-03-31 | cash_and_equivalents | 115,286,000 United States dollar | superseded | [clm_E7F616AB6B72](/claim/clm_E7F616AB6B72.md) ## 2018 - 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 37,576,000 United States dollar | superseded | [clm_2B65E08EE9A9](/claim/clm_2B65E08EE9A9.md) - 2018-03-31 to 2018-06-30 | total_assets | 482,795,000 United States dollar | superseded | [clm_2C4494D9E6E9](/claim/clm_2C4494D9E6E9.md) - 2018-03-31 to 2018-06-30 | quarterly_revenue | 129,116,000 United States dollar | superseded | [clm_4D8BDDDCBFF9](/claim/clm_4D8BDDDCBFF9.md) - 2018-03-31 to 2018-06-30 | total_equity | 362,540,000 United States dollar | superseded | [clm_6E604C4B4F38](/claim/clm_6E604C4B4F38.md) - 2018-03-31 to 2018-06-30 | quarterly_operating_income | -24,257,000 United States dollar | superseded | [clm_7C4F2EAE4318](/claim/clm_7C4F2EAE4318.md) - 2018-03-31 to 2018-06-30 | quarterly_net_income | -23,729,000 United States dollar | superseded | [clm_7F9EB3288581](/claim/clm_7F9EB3288581.md) - 2018-03-31 to 2018-06-30 | cash_and_equivalents | 117,737,000 United States dollar | superseded | [clm_D683D9FF1B2A](/claim/clm_D683D9FF1B2A.md) - 2018-06-30 to 2018-09-30 | total_equity | 429,671,000 United States dollar | superseded | [clm_03FBF4B93737](/claim/clm_03FBF4B93737.md) - 2018-06-30 to 2018-09-30 | total_assets | 985,848,000 United States dollar | superseded | [clm_525BD1DCDD06](/claim/clm_525BD1DCDD06.md) - 2018-06-30 to 2018-09-30 | quarterly_operating_income | -21,958,000 United States dollar | superseded | [clm_7B73F70D1856](/claim/clm_7B73F70D1856.md) - 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 39,811,000 United States dollar | superseded | [clm_7F500E2AAF04](/claim/clm_7F500E2AAF04.md) - 2018-06-30 to 2018-09-30 | quarterly_net_income | -24,006,000 United States dollar | superseded | [clm_8417820B00A0](/claim/clm_8417820B00A0.md) - 2018-06-30 to 2018-09-30 | cash_and_equivalents | 493,510,000 United States dollar | superseded | [clm_9EDFB4BE5DF0](/claim/clm_9EDFB4BE5DF0.md) - 2018-06-30 to 2018-09-30 | quarterly_revenue | 147,754,000 United States dollar | superseded | [clm_A7C92BBB516F](/claim/clm_A7C92BBB516F.md) - 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 42,340,000 United States dollar | superseded | [clm_2E17469EE6C2](/claim/clm_2E17469EE6C2.md) - 2018-09-30 to 2019-03-31 | quarterly_operating_income | -25,033,000 United States dollar | superseded | [clm_50BEF90F5163](/claim/clm_50BEF90F5163.md) - 2018-09-30 to 2018-12-31 | cash_and_equivalents | 469,132,000 United States dollar | superseded | [clm_5FC57CA108C8](/claim/clm_5FC57CA108C8.md) - 2018-09-30 to 2019-03-31 | quarterly_revenue | 168,895,000 United States dollar | superseded | [clm_A0F623F38C11](/claim/clm_A0F623F38C11.md) - 2018-09-30 to 2018-12-31 | total_equity | 434,353,000 United States dollar | superseded | [clm_B4694F789035](/claim/clm_B4694F789035.md) - 2018-09-30 to 2018-12-31 | total_assets | 1,003,797,000 United States dollar | superseded | [clm_B8D464317A7C](/claim/clm_B8D464317A7C.md) - 2018-09-30 to 2019-03-31 | quarterly_net_income | -27,056,000 United States dollar | superseded | [clm_BB439FAC6C41](/claim/clm_BB439FAC6C41.md) - 2018-12-31 to 2019-03-31 | cash_and_equivalents | 487,215,000 United States dollar | superseded | [clm_0BF152C399DC](/claim/clm_0BF152C399DC.md) - 2018-12-31 to 2019-12-31 | research_and_development | 171,358,000 United States dollar | superseded | [clm_14F9657BBDF0](/claim/clm_14F9657BBDF0.md) - 2018-12-31 to 2019-12-31 | operating_income | -115,235,000 United States dollar | superseded | [clm_3330CA79784A](/claim/clm_3330CA79784A.md) - 2018-12-31 to 2019-12-31 | revenue | 650,067,000 United States dollar | superseded | [clm_85A91F79F336](/claim/clm_85A91F79F336.md) - 2018-12-31 to 2019-03-31 | total_equity | 438,235,000 United States dollar | superseded | [clm_970BC3D06350](/claim/clm_970BC3D06350.md) - 2018-12-31 to 2019-12-31 | net_income | -121,949,000 United States dollar | superseded | [clm_BF5B99051ED8](/claim/clm_BF5B99051ED8.md) - 2018-12-31 to 2019-03-31 | total_assets | 1,028,710,000 United States dollar | superseded | [clm_E03B62946316](/claim/clm_E03B62946316.md) ## 2019 - 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 77,855,000 United States dollar | superseded | [clm_0170C4BC6245](/claim/clm_0170C4BC6245.md) - 2019-03-31 to 2019-06-30 | total_equity | 3,327,513,000 United States dollar | superseded | [clm_2E15D97168F0](/claim/clm_2E15D97168F0.md) - 2019-03-31 to 2019-06-30 | quarterly_revenue | 233,139,000 United States dollar | superseded | [clm_3768D87E9384](/claim/clm_3768D87E9384.md) - 2019-03-31 to 2019-06-30 | total_assets | 4,120,073,000 United States dollar | superseded | [clm_58906599514B](/claim/clm_58906599514B.md) - 2019-03-31 to 2019-06-30 | cash_and_equivalents | 377,730,000 United States dollar | superseded | [clm_76B757510CB4](/claim/clm_76B757510CB4.md) - 2019-03-31 to 2019-06-30 | quarterly_net_income | -36,503,000 United States dollar | superseded | [clm_76BE4C8E590C](/claim/clm_76BE4C8E590C.md) - 2019-03-31 to 2019-06-30 | quarterly_operating_income | -87,588,000 United States dollar | superseded | [clm_C8233E148155](/claim/clm_C8233E148155.md) - 2019-06-30 to 2019-09-30 | total_assets | 5,109,105,000 United States dollar | superseded | [clm_0F8D1F26CE2D](/claim/clm_0F8D1F26CE2D.md) - 2019-06-30 to 2019-09-30 | quarterly_net_income | -92,579,000 United States dollar | superseded | [clm_319F628ADEAE](/claim/clm_319F628ADEAE.md) - 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 98,783,000 United States dollar | superseded | [clm_3EE8B8BA3B26](/claim/clm_3EE8B8BA3B26.md) - 2019-06-30 to 2019-09-30 | quarterly_revenue | 275,039,000 United States dollar | superseded | [clm_4ECC25D3AB98](/claim/clm_4ECC25D3AB98.md) - 2019-06-30 to 2019-09-30 | total_equity | 4,296,860,000 United States dollar | superseded | [clm_787B576EBEB2](/claim/clm_787B576EBEB2.md) - 2019-06-30 to 2019-09-30 | quarterly_operating_income | -93,732,000 United States dollar | superseded | [clm_CDD480ADD10E](/claim/clm_CDD480ADD10E.md) - 2019-06-30 to 2019-09-30 | cash_and_equivalents | 535,911,000 United States dollar | superseded | [clm_D85282867007](/claim/clm_D85282867007.md) - 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 104,481,000 United States dollar | superseded | [clm_0B15ED982170](/claim/clm_0B15ED982170.md) - 2019-09-30 to 2020-03-31 | quarterly_revenue | 295,066,000 United States dollar | superseded | [clm_3C046E230202](/claim/clm_3C046E230202.md) - 2019-09-30 to 2019-12-31 | total_assets | 5,110,168,000 United States dollar | superseded | [clm_3E727B075E3F](/claim/clm_3E727B075E3F.md) - 2019-09-30 to 2019-12-31 | cash_and_equivalents | 330,601,000 United States dollar | superseded | [clm_754396FDB44D](/claim/clm_754396FDB44D.md) - 2019-09-30 to 2020-03-31 | quarterly_operating_income | -94,666,000 United States dollar | superseded | [clm_7980E61CC547](/claim/clm_7980E61CC547.md) - 2019-09-30 to 2020-03-31 | quarterly_net_income | -87,734,000 United States dollar | superseded | [clm_BF1DDFF2EF4F](/claim/clm_BF1DDFF2EF4F.md) - 2019-09-30 to 2019-12-31 | total_equity | 4,284,486,000 United States dollar | superseded | [clm_E9A2FBF76FB8](/claim/clm_E9A2FBF76FB8.md) - 2019-12-31 to 2020-06-30 | cash_and_equivalents | 253,660,000 United States dollar | superseded | [clm_085F91407B45](/claim/clm_085F91407B45.md) - 2019-12-31 to 2020-12-31 | net_income | -307,063,000 United States dollar | superseded | [clm_1594940E79A3](/claim/clm_1594940E79A3.md) - 2019-12-31 to 2020-12-31 | operating_income | -369,785,000 United States dollar | superseded | [clm_21FAC4455752](/claim/clm_21FAC4455752.md) - 2019-12-31 to 2020-12-31 | research_and_development | 391,355,000 United States dollar | superseded | [clm_3C47F899E990](/claim/clm_3C47F899E990.md) - 2019-12-31 to 2020-03-31 | total_equity | 4,279,411,000 United States dollar | superseded | [clm_3F653DABFDE5](/claim/clm_3F653DABFDE5.md) - 2019-12-31 to 2020-12-31 | revenue | 1,134,468,000 United States dollar | superseded | [clm_B832FA891CEA](/claim/clm_B832FA891CEA.md) - 2019-12-31 to 2020-09-30 | total_assets | 5,150,516,000 United States dollar | superseded | [clm_F8FC1701D6F7](/claim/clm_F8FC1701D6F7.md) ## 2020 - 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 114,339,000 United States dollar | superseded | [clm_336E275C9FCB](/claim/clm_336E275C9FCB.md) - 2020-03-31 to 2020-06-30 | quarterly_revenue | 364,868,000 United States dollar | superseded | [clm_39A9B6B6D18F](/claim/clm_39A9B6B6D18F.md) - 2020-03-31 to 2020-06-30 | quarterly_net_income | -94,791,000 United States dollar | superseded | [clm_443840714A99](/claim/clm_443840714A99.md) - 2020-03-31 to 2020-06-30 | total_equity | 4,256,525,000 United States dollar | superseded | [clm_894D08D5A929](/claim/clm_894D08D5A929.md) - 2020-03-31 to 2020-06-30 | quarterly_operating_income | -92,696,000 United States dollar | superseded | [clm_C137AB04CC4D](/claim/clm_C137AB04CC4D.md) - 2020-06-30 to 2020-09-30 | quarterly_operating_income | -102,644,000 United States dollar | superseded | [clm_30FAFBF68E1C](/claim/clm_30FAFBF68E1C.md) - 2020-06-30 to 2020-09-30 | quarterly_net_income | -99,923,000 United States dollar | superseded | [clm_55BA4436AC2F](/claim/clm_55BA4436AC2F.md) - 2020-06-30 to 2020-09-30 | total_equity | 4,321,590,000 United States dollar | superseded | [clm_8F9D284B91D6](/claim/clm_8F9D284B91D6.md) - 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 120,701,000 United States dollar | superseded | [clm_A29731EE8F28](/claim/clm_A29731EE8F28.md) - 2020-06-30 to 2020-09-30 | cash_and_equivalents | 475,700,000 United States dollar | superseded | [clm_D2CD337FDB32](/claim/clm_D2CD337FDB32.md) - 2020-06-30 to 2020-09-30 | quarterly_revenue | 400,849,000 United States dollar | superseded | [clm_DAFD03E601FF](/claim/clm_DAFD03E601FF.md) - 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 136,652,000 United States dollar | superseded | [clm_09E011AAEE53](/claim/clm_09E011AAEE53.md) - 2020-09-30 to 2021-03-31 | quarterly_operating_income | -112,270,000 United States dollar | superseded | [clm_0A47E8A6603E](/claim/clm_0A47E8A6603E.md) - 2020-09-30 to 2020-12-31 | cash_and_equivalents | 1,127,102,000 United States dollar | superseded | [clm_13B35B8BBCE4](/claim/clm_13B35B8BBCE4.md) - 2020-09-30 to 2021-03-31 | quarterly_revenue | 447,969,000 United States dollar | superseded | [clm_5EF0767DB623](/claim/clm_5EF0767DB623.md) - 2020-09-30 to 2020-12-31 | total_equity | 5,762,268,000 United States dollar | superseded | [clm_6F3BEAD43F96](/claim/clm_6F3BEAD43F96.md) - 2020-09-30 to 2020-12-31 | total_assets | 6,723,702,000 United States dollar | superseded | [clm_E17F082282E9](/claim/clm_E17F082282E9.md) - 2020-09-30 to 2021-03-31 | quarterly_net_income | -116,914,000 United States dollar | superseded | [clm_E628A2EA5415](/claim/clm_E628A2EA5415.md) - 2020-12-31 to 2021-03-31 | total_equity | 8,452,665,000 United States dollar | superseded | [clm_01C2CCE1592E](/claim/clm_01C2CCE1592E.md) - 2020-12-31 to 2021-12-31 | net_income | -490,979,000 United States dollar | superseded | [clm_5D08AA20CDF8](/claim/clm_5D08AA20CDF8.md) - 2020-12-31 to 2021-03-31 | cash_and_equivalents | 933,885,000 United States dollar | superseded | [clm_A178019EF84A](/claim/clm_A178019EF84A.md) - 2020-12-31 to 2021-12-31 | operating_income | -492,901,000 United States dollar | superseded | [clm_A93767F9E8D3](/claim/clm_A93767F9E8D3.md) - 2020-12-31 to 2021-03-31 | total_assets | 9,487,433,000 United States dollar | superseded | [clm_C29282C4B91A](/claim/clm_C29282C4B91A.md) - 2020-12-31 to 2021-12-31 | research_and_development | 530,548,000 United States dollar | superseded | [clm_CCE9A74B4125](/claim/clm_CCE9A74B4125.md) - 2020-12-31 to 2021-12-31 | revenue | 1,761,776,000 United States dollar | superseded | [clm_F77CA9D6E783](/claim/clm_F77CA9D6E783.md) ## 2021 - 2021-03-31 to 2021-06-30 | total_equity | 10,247,196,000 United States dollar | superseded | [clm_19EC5014A916](/claim/clm_19EC5014A916.md) - 2021-03-31 to 2021-06-30 | total_assets | 12,242,181,000 United States dollar | superseded | [clm_21A492E7D18E](/claim/clm_21A492E7D18E.md) - 2021-03-31 to 2021-06-30 | quarterly_operating_income | -197,339,000 United States dollar | superseded | [clm_2228A2E86C8E](/claim/clm_2228A2E86C8E.md) - 2021-03-31 to 2021-06-30 | quarterly_revenue | 589,988,000 United States dollar | superseded | [clm_2602B2933442](/claim/clm_2602B2933442.md) - 2021-03-31 to 2021-06-30 | cash_and_equivalents | 2,331,774,000 United States dollar | superseded | [clm_64F2C68ED9B0](/claim/clm_64F2C68ED9B0.md) - 2021-03-31 to 2021-06-30 | quarterly_net_income | -206,542,000 United States dollar | superseded | [clm_68EFD80A0FF7](/claim/clm_68EFD80A0FF7.md) - 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 174,800,000 United States dollar | superseded | [clm_726A0C1F734E](/claim/clm_726A0C1F734E.md) - 2021-06-30 to 2021-09-30 | total_equity | 10,694,112,000 United States dollar | superseded | [clm_47B3D2208E3C](/claim/clm_47B3D2208E3C.md) - 2021-06-30 to 2021-09-30 | quarterly_net_income | -227,853,000 United States dollar | superseded | [clm_503D70A5C571](/claim/clm_503D70A5C571.md) - 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 181,280,000 United States dollar | superseded | [clm_65D84AE6BE16](/claim/clm_65D84AE6BE16.md) - 2021-06-30 to 2021-09-30 | quarterly_revenue | 668,931,000 United States dollar | superseded | [clm_759DCD066506](/claim/clm_759DCD066506.md) - 2021-06-30 to 2021-09-30 | quarterly_operating_income | -202,274,000 United States dollar | superseded | [clm_8F091E3B628F](/claim/clm_8F091E3B628F.md) - 2021-06-30 to 2021-09-30 | cash_and_equivalents | 1,799,602,000 United States dollar | superseded | [clm_B80A1DCEB2A4](/claim/clm_B80A1DCEB2A4.md) - 2021-06-30 to 2021-09-30 | total_assets | 12,533,585,000 United States dollar | superseded | [clm_B8C8E4EE6C8F](/claim/clm_B8C8E4EE6C8F.md) - 2021-09-30 to 2021-12-31 | cash_and_equivalents | 1,497,498,000 United States dollar | superseded | [clm_0CFF09DFF886](/claim/clm_0CFF09DFF886.md) - 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 209,890,000 United States dollar | superseded | [clm_21644742D7B7](/claim/clm_21644742D7B7.md) - 2021-09-30 to 2022-03-31 | quarterly_revenue | 740,176,000 United States dollar | superseded | [clm_8881B7F972CD](/claim/clm_8881B7F972CD.md) - 2021-09-30 to 2021-12-31 | total_equity | 11,081,749,000 United States dollar | superseded | [clm_BA51C3965651](/claim/clm_BA51C3965651.md) - 2021-09-30 to 2022-03-31 | quarterly_net_income | -224,109,000 United States dollar | superseded | [clm_C3638DC152CB](/claim/clm_C3638DC152CB.md) - 2021-09-30 to 2022-03-31 | quarterly_operating_income | -232,345,000 United States dollar | superseded | [clm_E1328A3981AE](/claim/clm_E1328A3981AE.md) - 2021-09-30 to 2021-12-31 | total_assets | 12,976,847,000 United States dollar | superseded | [clm_EFB71B81E568](/claim/clm_EFB71B81E568.md) - 2021-12-31 to 2022-12-31 | research_and_development | 789,219,000 United States dollar | superseded | [clm_1C240A7249BA](/claim/clm_1C240A7249BA.md) - 2021-12-31 to 2022-12-31 | operating_income | -915,584,000 United States dollar | superseded | [clm_1DA54E925B4F](/claim/clm_1DA54E925B4F.md) - 2021-12-31 to 2022-12-31 | net_income | -949,900,000 United States dollar | superseded | [clm_5A1B62295BD2](/claim/clm_5A1B62295BD2.md) - 2021-12-31 to 2022-03-31 | total_assets | 12,998,598,000 United States dollar | superseded | [clm_68AE0996739E](/claim/clm_68AE0996739E.md) - 2021-12-31 to 2022-03-31 | cash_and_equivalents | 1,479,452,000 United States dollar | superseded | [clm_C2BBF546A527](/claim/clm_C2BBF546A527.md) - 2021-12-31 to 2022-03-31 | total_equity | 11,031,466,000 United States dollar | superseded | [clm_EC0610391773](/claim/clm_EC0610391773.md) - 2021-12-31 to 2022-12-31 | revenue | 2,841,839,000 United States dollar | superseded | [clm_ED0088ED3D1C](/claim/clm_ED0088ED3D1C.md) ## 2022 - 2022-03-31 to 2022-06-30 | quarterly_net_income | -221,627,000 United States dollar | superseded | [clm_58DC9AF47BFE](/claim/clm_58DC9AF47BFE.md) - 2022-03-31 to 2022-06-30 | total_assets | 12,890,802,000 United States dollar | superseded | [clm_7691FC97CCA2](/claim/clm_7691FC97CCA2.md) - 2022-03-31 to 2022-06-30 | quarterly_revenue | 875,363,000 United States dollar | superseded | [clm_9B7C04ED0631](/claim/clm_9B7C04ED0631.md) - 2022-03-31 to 2022-06-30 | cash_and_equivalents | 1,617,022,000 United States dollar | superseded | [clm_AC2003917AD3](/claim/clm_AC2003917AD3.md) - 2022-03-31 to 2022-06-30 | quarterly_operating_income | -217,808,000 United States dollar | superseded | [clm_AC8C43E55B1F](/claim/clm_AC8C43E55B1F.md) - 2022-03-31 to 2022-06-30 | total_equity | 10,917,433,000 United States dollar | superseded | [clm_D63B7CBD67AD](/claim/clm_D63B7CBD67AD.md) - 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 240,611,000 United States dollar | superseded | [clm_D949228EE089](/claim/clm_D949228EE089.md) - 2022-06-30 to 2022-09-30 | quarterly_revenue | 943,354,000 United States dollar | superseded | [clm_4D981BB776F9](/claim/clm_4D981BB776F9.md) - 2022-06-30 to 2022-09-30 | quarterly_net_income | -322,769,000 United States dollar | superseded | [clm_6E664C5D91F7](/claim/clm_6E664C5D91F7.md) - 2022-06-30 to 2022-09-30 | total_equity | 10,841,995,000 United States dollar | superseded | [clm_784B31D52236](/claim/clm_784B31D52236.md) - 2022-06-30 to 2022-09-30 | cash_and_equivalents | 798,625,000 United States dollar | superseded | [clm_8B20D248D22F](/claim/clm_8B20D248D22F.md) - 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 279,641,000 United States dollar | superseded | [clm_973BB3D3F787](/claim/clm_973BB3D3F787.md) - 2022-06-30 to 2022-09-30 | total_assets | 12,869,229,000 United States dollar | superseded | [clm_9D81592D46B8](/claim/clm_9D81592D46B8.md) - 2022-06-30 to 2022-09-30 | quarterly_operating_income | -311,936,000 United States dollar | superseded | [clm_CB36DA85CCAD](/claim/clm_CB36DA85CCAD.md) - 2022-09-30 to 2023-03-31 | quarterly_revenue | 983,030,000 United States dollar | superseded | [clm_358BBCBE4449](/claim/clm_358BBCBE4449.md) - 2022-09-30 to 2023-03-31 | quarterly_operating_income | -456,997,000 United States dollar | superseded | [clm_371885608485](/claim/clm_371885608485.md) - 2022-09-30 to 2023-03-31 | quarterly_net_income | -482,327,000 United States dollar | superseded | [clm_7FA03265585E](/claim/clm_7FA03265585E.md) - 2022-09-30 to 2022-12-31 | total_assets | 12,612,656,000 United States dollar | superseded | [clm_AC893774C4C9](/claim/clm_AC893774C4C9.md) - 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 284,735,000 United States dollar | superseded | [clm_AE85FFB9A1CE](/claim/clm_AE85FFB9A1CE.md) - 2022-09-30 to 2022-12-31 | total_equity | 10,530,888,000 United States dollar | superseded | [clm_B61190EEB195](/claim/clm_B61190EEB195.md) - 2022-09-30 to 2022-12-31 | cash_and_equivalents | 632,794,000 United States dollar | superseded | [clm_C2060008FE55](/claim/clm_C2060008FE55.md) - 2022-12-31 to 2023-03-31 | total_assets | 12,564,304,000 United States dollar | superseded | [clm_2E965284CB57](/claim/clm_2E965284CB57.md) - 2022-12-31 to 2023-12-31 | research_and_development | 1,079,081,000 United States dollar | superseded | [clm_2F7F09879539](/claim/clm_2F7F09879539.md) - 2022-12-31 to 2023-12-31 | revenue | 3,826,321,000 United States dollar | superseded | [clm_37BC552AA816](/claim/clm_37BC552AA816.md) - 2022-12-31 to 2023-03-31 | total_equity | 10,559,042,000 United States dollar | superseded | [clm_7890E7CE4CAE](/claim/clm_7890E7CE4CAE.md) - 2022-12-31 to 2023-03-31 | cash_and_equivalents | 651,752,000 United States dollar | superseded | [clm_B8120E7E0302](/claim/clm_B8120E7E0302.md) - 2022-12-31 to 2023-12-31 | net_income | -1,256,145,000 United States dollar | superseded | [clm_D46AED8A89BC](/claim/clm_D46AED8A89BC.md) - 2022-12-31 to 2023-12-31 | operating_income | -1,205,308,000 United States dollar | superseded | [clm_DAB08FD56C91](/claim/clm_DAB08FD56C91.md) ## 2023 - 2023-03-01 | president | Khozema Shipchandler | valid | [clm_25690D9B2DA1](/claim/clm_25690D9B2DA1.md) - 2023-03-01 | president | Elena Donio | valid | [clm_71587E66178D](/claim/clm_71587E66178D.md) - 2023-03-01 | cfo | Aidan Viggiano | valid | [clm_86CC37AC0A29](/claim/clm_86CC37AC0A29.md) - 2023-03-28 | board_member | Charles Bell | valid | [clm_44447CD40C22](/claim/clm_44447CD40C22.md) - 2023-03-31 to 2023-06-30 | total_equity | 10,318,866,000 United States dollar | superseded | [clm_1F372ED62C92](/claim/clm_1F372ED62C92.md) - 2023-03-31 to 2023-06-30 | total_assets | 12,298,908,000 United States dollar | superseded | [clm_3B11F1181F09](/claim/clm_3B11F1181F09.md) - 2023-03-31 to 2023-06-30 | cash_and_equivalents | 634,824,000 United States dollar | superseded | [clm_990C310D3C12](/claim/clm_990C310D3C12.md) - 2023-03-31 to 2023-06-30 | quarterly_revenue | 1,006,564,000 United States dollar | superseded | [clm_B26AA0BFF0B6](/claim/clm_B26AA0BFF0B6.md) - 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 238,595,000 United States dollar | superseded | [clm_B9AFC8965E67](/claim/clm_B9AFC8965E67.md) - 2023-03-31 to 2023-06-30 | quarterly_operating_income | -264,084,000 United States dollar | superseded | [clm_B9C11EAE43CA](/claim/clm_B9C11EAE43CA.md) - 2023-03-31 to 2023-06-30 | quarterly_net_income | -342,139,000 United States dollar | superseded | [clm_EFB20E6B9D25](/claim/clm_EFB20E6B9D25.md) - 2023-06-30 to 2023-09-30 | cash_and_equivalents | 675,081,000 United States dollar | superseded | [clm_0E86C9647F53](/claim/clm_0E86C9647F53.md) - 2023-06-30 to 2023-09-30 | total_equity | 9,976,559,000 United States dollar | superseded | [clm_9B46D6C09FDE](/claim/clm_9B46D6C09FDE.md) - 2023-06-30 to 2023-09-30 | quarterly_net_income | -166,187,000 United States dollar | superseded | [clm_9B972BCCA21C](/claim/clm_9B972BCCA21C.md) - 2023-06-30 to 2023-09-30 | quarterly_operating_income | -141,827,000 United States dollar | superseded | [clm_A8CE51096F4E](/claim/clm_A8CE51096F4E.md) - 2023-06-30 to 2023-09-30 | total_assets | 11,904,486,000 United States dollar | superseded | [clm_C4BD0781A76D](/claim/clm_C4BD0781A76D.md) - 2023-06-30 to 2023-09-30 | quarterly_revenue | 1,037,761,000 United States dollar | superseded | [clm_EEC598B4D9DC](/claim/clm_EEC598B4D9DC.md) - 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 226,896,000 United States dollar | superseded | [clm_F15F331D81A0](/claim/clm_F15F331D81A0.md) - 2023-09-30 to 2024-03-31 | quarterly_net_income | -141,707,000 United States dollar | superseded | [clm_285493F3C7EF](/claim/clm_285493F3C7EF.md) - 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 241,654,000 United States dollar | superseded | [clm_4D39053F8392](/claim/clm_4D39053F8392.md) - 2023-09-30 to 2023-12-31 | cash_and_equivalents | 677,917,000 United States dollar | superseded | [clm_7D27B5CEDAAE](/claim/clm_7D27B5CEDAAE.md) - 2023-09-30 to 2024-03-31 | quarterly_revenue | 1,033,670,000 United States dollar | superseded | [clm_7D8DFF920387](/claim/clm_7D8DFF920387.md) - 2023-09-30 to 2024-03-31 | quarterly_operating_income | -108,903,000 United States dollar | superseded | [clm_80623909E610](/claim/clm_80623909E610.md) - 2023-09-30 to 2023-12-31 | total_equity | 9,979,381,000 United States dollar | superseded | [clm_BEBA3CE89A57](/claim/clm_BEBA3CE89A57.md) - 2023-09-30 to 2023-12-31 | total_assets | 11,857,738,000 United States dollar | superseded | [clm_DC53FC87A394](/claim/clm_DC53FC87A394.md) - 2023-11-01 to 2024-05-01 | shares_outstanding | 181,042,862 shares | superseded | [clm_FA1B8A9FC190](/claim/clm_FA1B8A9FC190.md) - 2023-12-31 to 2024-03-31 | total_equity | 9,732,552,000 United States dollar | superseded | [clm_14690582DF02](/claim/clm_14690582DF02.md) - 2023-12-31 to 2024-12-31 | operating_income | -876,541,000 United States dollar | superseded | [clm_23EC98B6CC53](/claim/clm_23EC98B6CC53.md) - 2023-12-31 to 2024-12-31 | research_and_development | 942,790,000 United States dollar | superseded | [clm_257046533F20](/claim/clm_257046533F20.md) - 2023-12-31 to 2024-03-31 | cash_and_equivalents | 655,931,000 United States dollar | superseded | [clm_4FD9EBC9578C](/claim/clm_4FD9EBC9578C.md) - 2023-12-31 to 2024-12-31 | net_income | -1,015,441,000 United States dollar | superseded | [clm_52E2DE3F2D19](/claim/clm_52E2DE3F2D19.md) - 2023-12-31 to 2024-03-31 | total_assets | 11,609,707,000 United States dollar | superseded | [clm_B0991B690631](/claim/clm_B0991B690631.md) - 2023-12-31 to 2024-12-31 | revenue | 4,153,945,000 United States dollar | superseded | [clm_C414C4162F97](/claim/clm_C414C4162F97.md) ## 2024 - 2024-01-08 | ceo | Khozema Shipchandler | valid | [clm_2EDE04F74790](/claim/clm_2EDE04F74790.md) - 2024-01-08 | board_member | Khozema Shipchandler | valid | [clm_B152FC5AB321](/claim/clm_B152FC5AB321.md) - 2024-01-08 | chair | Jeff Epstein | valid | [clm_BFD2E4CA559D](/claim/clm_BFD2E4CA559D.md) - 2024-03-30 | board_member | Andy J. Stafman | valid | [clm_2A1558BA452E](/claim/clm_2A1558BA452E.md) - 2024-03-31 to 2024-06-30 | quarterly_operating_income | -43,504,000 United States dollar | superseded | [clm_24581227F606](/claim/clm_24581227F606.md) - 2024-03-31 to 2024-06-30 | quarterly_net_income | -55,349,000 United States dollar | superseded | [clm_36503AB86578](/claim/clm_36503AB86578.md) - 2024-03-31 to 2024-06-30 | total_assets | 11,289,289,000 United States dollar | superseded | [clm_4CAC863A7BA1](/claim/clm_4CAC863A7BA1.md) - 2024-03-31 to 2024-06-30 | cash_and_equivalents | 672,595,000 United States dollar | superseded | [clm_4EA1D8340EB2](/claim/clm_4EA1D8340EB2.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 251,615,000 United States dollar | superseded | [clm_6C94771DCC1D](/claim/clm_6C94771DCC1D.md) - 2024-03-31 to 2024-06-30 | total_equity | 9,447,730,000 United States dollar | superseded | [clm_8C8FF349E578](/claim/clm_8C8FF349E578.md) - 2024-03-31 to 2024-06-30 | quarterly_revenue | 1,047,050,000 United States dollar | superseded | [clm_DEDB9C5B47B3](/claim/clm_DEDB9C5B47B3.md) - 2024-05-01 to 2024-07-23 | shares_outstanding | 171,171,739 shares | superseded | [clm_404927779B24](/claim/clm_404927779B24.md) - 2024-06-30 to 2024-09-30 | quarterly_net_income | -31,858,000 United States dollar | superseded | [clm_3AC909992903](/claim/clm_3AC909992903.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 243,652,000 United States dollar | superseded | [clm_4C7D5A50F76C](/claim/clm_4C7D5A50F76C.md) - 2024-06-30 to 2024-09-30 | cash_and_equivalents | 755,065,000 United States dollar | superseded | [clm_85A2E2DE8B3E](/claim/clm_85A2E2DE8B3E.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 1,082,502,000 United States dollar | superseded | [clm_91B2D723F9AF](/claim/clm_91B2D723F9AF.md) - 2024-06-30 to 2024-09-30 | total_assets | 10,507,652,000 United States dollar | superseded | [clm_93AA7C19312B](/claim/clm_93AA7C19312B.md) - 2024-06-30 to 2024-09-30 | total_equity | 8,679,473,000 United States dollar | superseded | [clm_97C183CD2329](/claim/clm_97C183CD2329.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | -19,037,000 United States dollar | superseded | [clm_A27215140110](/claim/clm_A27215140110.md) - 2024-07-23 to 2024-10-24 | shares_outstanding | 160,599,847 shares | superseded | [clm_CBB4BDDB343D](/claim/clm_CBB4BDDB343D.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 1,133,649,000 United States dollar | superseded | [clm_1AA3DA5875EF](/claim/clm_1AA3DA5875EF.md) - 2024-09-30 to 2024-12-31 | cash_and_equivalents | 583,969,000 United States dollar | superseded | [clm_2C16DD7F0172](/claim/clm_2C16DD7F0172.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | -4,894,000 United States dollar | superseded | [clm_309BE436BCCF](/claim/clm_309BE436BCCF.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 260,903,000 United States dollar | superseded | [clm_34253CE0CBAF](/claim/clm_34253CE0CBAF.md) - 2024-09-30 to 2025-03-31 | quarterly_net_income | -9,726,000 United States dollar | superseded | [clm_352B65838714](/claim/clm_352B65838714.md) - 2024-09-30 to 2024-12-31 | total_assets | 10,037,257,000 United States dollar | superseded | [clm_B7A90FC586E8](/claim/clm_B7A90FC586E8.md) - 2024-09-30 to 2024-12-31 | total_equity | 8,228,867,000 United States dollar | superseded | [clm_E083CF39F88B](/claim/clm_E083CF39F88B.md) - 2024-10-24 to 2025-02-14 | shares_outstanding | 153,383,697 shares | superseded | [clm_7D694DE96281](/claim/clm_7D694DE96281.md) - 2024-12-31 to 2025-12-31 | revenue | 4,458,036,000 United States dollar | superseded | [clm_48EE676DD345](/claim/clm_48EE676DD345.md) - 2024-12-31 to 2025-12-31 | research_and_development | 1,008,747,000 United States dollar | superseded | [clm_4D5CF359C71B](/claim/clm_4D5CF359C71B.md) - 2024-12-31 to 2025-03-31 | total_assets | 9,865,472,000 United States dollar | superseded | [clm_71E1C0583FA3](/claim/clm_71E1C0583FA3.md) - 2024-12-31 to 2025-12-31 | net_income | -109,403,000 United States dollar | superseded | [clm_7F8F6E1FFB93](/claim/clm_7F8F6E1FFB93.md) - 2024-12-31 to 2025-03-31 | total_equity | 7,952,966,000 United States dollar | superseded | [clm_916A590C0AFF](/claim/clm_916A590C0AFF.md) - 2024-12-31 to 2025-12-31 | operating_income | -53,708,000 United States dollar | superseded | [clm_92720A3AA15F](/claim/clm_92720A3AA15F.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 421,297,000 United States dollar | superseded | [clm_F8B6B39149DA](/claim/clm_F8B6B39149DA.md) ## 2025 - 2025-02-14 to 2025-04-15 | shares_outstanding | 152,633,605 shares | superseded | [clm_FDC777C80EA5](/claim/clm_FDC777C80EA5.md) - 2025-03-31 to 2025-06-30 | quarterly_revenue | 1,172,463,000 United States dollar | superseded | [clm_0EDAAE4B59DE](/claim/clm_0EDAAE4B59DE.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 254,295,000 United States dollar | superseded | [clm_4A59D93ADFF5](/claim/clm_4A59D93ADFF5.md) - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 467,094,000 United States dollar | superseded | [clm_5DA0FAA39EC0](/claim/clm_5DA0FAA39EC0.md) - 2025-03-31 to 2025-06-30 | total_equity | 8,004,291,000 United States dollar | superseded | [clm_BC3C6D533542](/claim/clm_BC3C6D533542.md) - 2025-03-31 to 2025-06-30 | quarterly_operating_income | 23,082,000 United States dollar | superseded | [clm_CC97A7DD587F](/claim/clm_CC97A7DD587F.md) - 2025-03-31 to 2025-06-30 | total_assets | 9,814,715,000 United States dollar | superseded | [clm_CF8672C5B920](/claim/clm_CF8672C5B920.md) - 2025-03-31 to 2025-06-30 | quarterly_net_income | 20,017,000 United States dollar | superseded | [clm_DADF97BFEC6E](/claim/clm_DADF97BFEC6E.md) - 2025-04-15 to 2025-07-25 | shares_outstanding | 152,674,214 shares | superseded | [clm_D4F6AFA0C6C8](/claim/clm_D4F6AFA0C6C8.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | 36,989,000 United States dollar | superseded | [clm_03B91B737155](/claim/clm_03B91B737155.md) - 2025-06-30 to 2025-09-30 | quarterly_net_income | 22,423,000 United States dollar | superseded | [clm_0E88BC7E2F2D](/claim/clm_0E88BC7E2F2D.md) - 2025-06-30 to 2025-09-30 | total_assets | 9,848,292,000 United States dollar | superseded | [clm_1C52911115DB](/claim/clm_1C52911115DB.md) - 2025-06-30 to 2025-09-30 | total_equity | 8,043,922,000 United States dollar | superseded | [clm_BB39062667D2](/claim/clm_BB39062667D2.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 1,228,425,000 United States dollar | superseded | [clm_DE9F41ED700D](/claim/clm_DE9F41ED700D.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 243,495,000 United States dollar | superseded | [clm_EF7398E3B845](/claim/clm_EF7398E3B845.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 969,229,000 United States dollar | superseded | [clm_F9FE35EFFC5D](/claim/clm_F9FE35EFFC5D.md) - 2025-07-25 to 2025-10-17 | shares_outstanding | 153,433,606 shares | superseded | [clm_B75D0752ECC1](/claim/clm_B75D0752ECC1.md) - 2025-09-30 to 2025-12-31 | total_equity | 7,895,289,000 United States dollar | superseded | [clm_0608C145E4D7](/claim/clm_0608C145E4D7.md) - 2025-09-30 to 2026-03-31 | quarterly_net_income | 37,248,000 United States dollar | superseded | [clm_0F4F48D38606](/claim/clm_0F4F48D38606.md) - 2025-09-30 to 2025-12-31 | total_assets | 9,712,319,000 United States dollar | superseded | [clm_1B4E6CD8185B](/claim/clm_1B4E6CD8185B.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | 40,948,000 United States dollar | superseded | [clm_88506BA044B7](/claim/clm_88506BA044B7.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 1,300,402,000 United States dollar | superseded | [clm_B4E7CBE03E21](/claim/clm_B4E7CBE03E21.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 262,311,000 United States dollar | superseded | [clm_DC4BEBBCFFED](/claim/clm_DC4BEBBCFFED.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 734,843,000 United States dollar | superseded | [clm_F8913598BC78](/claim/clm_F8913598BC78.md) - 2025-10-17 to 2026-02-10 | shares_outstanding | 151,612,818 shares | superseded | [clm_9A3E21E4723B](/claim/clm_9A3E21E4723B.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 682,335,000 United States dollar | superseded | [clm_046D36D57DD9](/claim/clm_046D36D57DD9.md) - 2025-12-31 | research_and_development | 1,020,159,000 United States dollar | valid | [clm_680BA7E10058](/claim/clm_680BA7E10058.md) - 2025-12-31 to 2026-03-31 | total_assets | 9,770,890,000 United States dollar | superseded | [clm_8ED5F593CC01](/claim/clm_8ED5F593CC01.md) - 2025-12-31 | net_income | 33,834,000 United States dollar | valid | [clm_CA426ED17C03](/claim/clm_CA426ED17C03.md) - 2025-12-31 | revenue | 5,067,220,000 United States dollar | valid | [clm_D3A9DD6F1A35](/claim/clm_D3A9DD6F1A35.md) - 2025-12-31 | operating_income | 157,802,000 United States dollar | valid | [clm_DD4285694C7A](/claim/clm_DD4285694C7A.md) - 2025-12-31 to 2026-03-31 | total_equity | 7,821,546,000 United States dollar | superseded | [clm_EC6F9FD76859](/claim/clm_EC6F9FD76859.md) ## 2026 - 2026-02-10 to 2026-04-17 | shares_outstanding | 151,513,999 shares | superseded | [clm_9F5E5B6D747A](/claim/clm_9F5E5B6D747A.md) - 2026-03-24 | board_member | Doug Robinson | valid | [clm_295694539224](/claim/clm_295694539224.md) - 2026-03-31 to 2026-06-30 | total_assets | 9,576,805,000 United States dollar | superseded | [clm_0D10036EAA0A](/claim/clm_0D10036EAA0A.md) - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 541,976,000 United States dollar | superseded | [clm_212836DB5705](/claim/clm_212836DB5705.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 1,406,907,000 United States dollar | superseded | [clm_30BEFBAFD8F4](/claim/clm_30BEFBAFD8F4.md) - 2026-03-31 to 2026-06-30 | quarterly_operating_income | 107,666,000 United States dollar | superseded | [clm_538146A4314A](/claim/clm_538146A4314A.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | 90,139,000 United States dollar | superseded | [clm_8EAFFC2D4004](/claim/clm_8EAFFC2D4004.md) - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 262,166,000 United States dollar | superseded | [clm_9D4ECA3A904B](/claim/clm_9D4ECA3A904B.md) - 2026-03-31 to 2026-06-30 | total_equity | 7,784,084,000 United States dollar | superseded | [clm_E475C0F09817](/claim/clm_E475C0F09817.md) - 2026-04-17 to 2026-07-24 | shares_outstanding | 151,773,860 shares | superseded | [clm_13474A5D33C1](/claim/clm_13474A5D33C1.md) - 2026-06-30 | quarterly_net_income | 1,067,209,000 United States dollar | valid | [clm_1673D81B7C6F](/claim/clm_1673D81B7C6F.md) - 2026-06-30 | total_assets | 10,838,627,000 United States dollar | valid | [clm_1D3FA0C51D81](/claim/clm_1D3FA0C51D81.md) - 2026-06-30 | quarterly_revenue | 1,499,089,000 United States dollar | valid | [clm_37E6DF3D134A](/claim/clm_37E6DF3D134A.md) - 2026-06-30 | total_equity | 8,977,808,000 United States dollar | valid | [clm_6477F1CAC2BC](/claim/clm_6477F1CAC2BC.md) - 2026-06-30 | cash_and_equivalents | 823,261,000 United States dollar | valid | [clm_761D537AC286](/claim/clm_761D537AC286.md) - 2026-06-30 | quarterly_operating_income | 84,546,000 United States dollar | valid | [clm_DFF8962EC0B4](/claim/clm_DFF8962EC0B4.md) - 2026-06-30 | quarterly_research_and_development | 273,317,000 United States dollar | valid | [clm_E09D00450C54](/claim/clm_E09D00450C54.md) - 2026-07-24 | shares_outstanding | 153,575,220 shares | valid | [clm_FFDDAA3AE651](/claim/clm_FFDDAA3AE651.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.